These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11931671)

  • 21. Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses.
    Dai E; Viswanathan K; Sun YM; Li X; Liu LY; Togonu-Bickersteth B; Richardson J; Macaulay C; Nash P; Turner P; Nazarian SH; Moyer R; McFadden G; Lucas AR
    J Biol Chem; 2006 Mar; 281(12):8041-50. PubMed ID: 16407226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of adsorption and proteolytic cleavage of a multilayer ovalbumin film by subtilisin Carlsberg.
    Foose LL; Blanch HW; Radke CJ
    Langmuir; 2008 Jul; 24(14):7388-93. PubMed ID: 18564867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 2.6 A structure of a serpin polymer and implications for conformational disease.
    Huntington JA; Pannu NS; Hazes B; Read RJ; Lomas DA; Carrell RW
    J Mol Biol; 1999 Oct; 293(3):449-55. PubMed ID: 10543942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the P1' specificity of the matrix metalloproteinases: effect of S1' pocket mutations in matrilysin and stromelysin-1.
    Welch AR; Holman CM; Huber M; Brenner MC; Browner MF; Van Wart HE
    Biochemistry; 1996 Aug; 35(31):10103-9. PubMed ID: 8756473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
    Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
    Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of ovalbumin as a model for the reactive centre of serpins.
    Stein PE; Leslie AG; Finch JT; Turnell WG; McLaughlin PJ; Carrell RW
    Nature; 1990 Sep; 347(6288):99-102. PubMed ID: 2395463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
    Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
    Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reaction of human chymase with reactive site variants of alpha 1-antichymotrypsin. Modulation of inhibitor versus substrate properties.
    Schechter NM; Jordan LM; James AM; Cooperman BS; Wang ZM; Rubin H
    J Biol Chem; 1993 Nov; 268(31):23626-33. PubMed ID: 8226889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory plant serpins with a sequence of three glutamine residues in the reactive center.
    Hejgaard J
    Biol Chem; 2005 Dec; 386(12):1319-23. PubMed ID: 16336127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of latency in plasminogen activator inhibitor-1.
    Mottonen J; Strand A; Symersky J; Sweet RM; Danley DE; Geoghegan KF; Gerard RD; Goldsmith EJ
    Nature; 1992 Jan; 355(6357):270-3. PubMed ID: 1731226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The kinetic mechanism of serpin-proteinase complex formation. An intermediate between the michaelis complex and the inhibited complex.
    O'Malley KM; Nair SA; Rubin H; Cooperman BS
    J Biol Chem; 1997 Feb; 272(8):5354-9. PubMed ID: 9030611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active site binding loop stabilization in the subtilisin inhibitor eglin c: structural and functional studies on specifically designed mutants in complex with subtilisin and the uncomplexed inhibitor.
    Hipler K; Priestle JP; Rahuel J; Grütter MG
    Adv Exp Med Biol; 1996; 379():43-7. PubMed ID: 8796309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and properties of ovalbumin.
    Huntington JA; Stein PE
    J Chromatogr B Biomed Sci Appl; 2001 May; 756(1-2):189-98. PubMed ID: 11419711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin.
    Plotnick MI; Rubin H; Schechter NM
    J Biol Chem; 2002 Aug; 277(33):29927-35. PubMed ID: 12055188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
    Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
    Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
    Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
    J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loop variants of the serpin thyroxine-binding globulin: implications for hormone release upon limited proteolysis.
    Grasberger H; Golcher HM; Fingerhut A; Janssen OE
    Biochem J; 2002 Jul; 365(Pt 1):311-6. PubMed ID: 11931635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1.
    Blouse GE; Perron MJ; Kvassman JO; Yunus S; Thompson JH; Betts RL; Lutter LC; Shore JD
    Biochemistry; 2003 Oct; 42(42):12260-72. PubMed ID: 14567688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis.
    Mast AE; Enghild JJ; Salvesen G
    Biochemistry; 1992 Mar; 31(10):2720-8. PubMed ID: 1547212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of cleaved vaspin (serpinA12).
    Pippel J; Kuettner EB; Ulbricht D; Daberger J; Schultz S; Heiker JT; Sträter N
    Biol Chem; 2016 Jan; 397(2):111-23. PubMed ID: 26529565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.